Recombinant Xenopus laevis Oxidoreductase NAD-binding domain-containing protein 1 (OXNAD1) is a protein that, in humans, is encoded by the OXNAD1 gene . It is predicted to have oxidoreductase activity and is located in the mitochondrion .
OXNAD1 is an oxidoreductase NAD-binding domain-containing protein 1 . The protein is produced in Yeast and can be purchased for research purposes .
The OXNAD1 gene encodes a protein with an oxidoreductase NAD-binding domain . The gene is also known as MGC15763 .
OXNAD1 exhibits general cytoplasmic expression, with additional membranous expression observed in several tissues .
Expression of OXNAD1 mRNA can be influenced by various compounds :
Increased expression: Tretinoin, aristolochic acid I, cobaltous chloride, flutamide, nefazodone, nimesulide, perfluorooctanoic acid, pirinixic acid, Soman, triptonide, and valproic acid .
Decreased expression: Arsenite, cadmium chloride, clofibrate, copper(II) sulfate, dicrotophos, doxorubicin, epoxiconazole, glycidol, permethrin, quercetin, sodium arsenite .
Affected expression: Dibutyl phosphate, paracetamol and triphenyl phosphate .
OXNAD1 (Oxidoreductase NAD-binding domain-containing protein 1) is a protein involved in oxidative stress response and regulation. In Xenopus laevis, this protein plays a significant role in cellular defense against oxidative stress, a process implicated in various diseases including cancer, neurodegenerative disorders, and cardiovascular conditions .
Xenopus laevis serves as an excellent model organism for OXNAD1 research due to several advantages:
The high conservation of developmental signaling programs between Xenopus and mammals
The large, easily manipulated embryos that facilitate protein expression studies
The well-characterized genomic information of Xenopus laevis, despite its allotetraploid nature (having four sets of chromosomes)
The recombinant OXNAD1 protein requires specific handling and storage protocols to maintain its stability and activity:
Preparation:
Express in E. coli expression systems (as described for product CSB-EP742471XBE-B)
Purify to >85% purity using appropriate chromatographic methods
Prior to opening the vial, briefly centrifuge to bring contents to the bottom
Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Storage Recommendations:
Add 5-50% glycerol (final concentration) and aliquot for long-term storage
Store at -20°C/-80°C (liquid form shelf life: 6 months; lyophilized form: 12 months)
For working aliquots, store at 4°C for up to one week
Several methodological approaches have proven effective for studying OXNAD1 in Xenopus:
Gene Expression Analysis:
RT-qPCR to measure OXNAD1 mRNA levels in different developmental stages
Microarray or RNA-seq analysis to identify expression patterns during metamorphosis
Genetic Manipulation:
CRISPR/Cas9-mediated gene editing: Using crRNA:tracrRNA approach with guide RNAs designed to target the OXNAD1 gene
sgRNA design using tools like CRISPRdirect and CRISPRscan
Analysis of genome editing efficiency using decomposition analysis
Protein Analysis:
Western blotting using specific antibodies (recommended dilution 1:1000-1:5000)
Functional Studies:
Gene expression knockdown using siRNA to assess effects on cell viability, cell growth, apoptosis, and oxidative stress response
Analysis of gene-chemical interactions to understand OXNAD1 regulation
Research has revealed important insights about OXNAD1's role in aging across species:
Expression Patterns:
OXNAD1 shows significant differential expression with chronological age. Studies comparing young and older individuals revealed:
| Species/Population | Expression Change with Age | Study Method | Sample Size |
|---|---|---|---|
| Asian (Chinese) | Significantly downregulated | RNA-seq | n=19 |
| Caucasian | Significantly downregulated | Microarray | n=89 |
| Women (across ethnicities) | Significantly downregulated | Combined analysis | n=124 |
These findings suggest OXNAD1 downregulation is a conserved feature of aging across different populations .
Functional Implications:
OXNAD1 appears to play important roles in:
Cellular metabolism pathways relevant to aging
Oxidative stress response mechanisms
Potential biomarker applications for aging assessment
The consistent downregulation of OXNAD1 in aging across diverse populations suggests it could serve as a reliable biomarker for biological aging processes .
Researchers face several important considerations when choosing between these two Xenopus species:
Genomic Complexity:
Xenopus laevis is allotetraploid (four sets of chromosomes), complicating genetic studies due to gene duplicates that could mask mutant phenotypes
Xenopus tropicalis is diploid, making it more suitable for genetic studies including mutation analysis
Experimental Advantages/Disadvantages:
| Feature | X. laevis | X. tropicalis | Implication for OXNAD1 Research |
|---|---|---|---|
| Genome complexity | Allotetraploid | Diploid | Potentially multiple OXNAD1 copies in X. laevis |
| Embryo size | Larger | Smaller | More material per X. laevis embryo for biochemical analysis |
| Generation time | ~12 months | ~4 months | Faster genetic studies in X. tropicalis |
| Cell-free systems | Well established | Less reliable | Better for X. laevis protein function studies |
| Established protocols | Extensive | Growing | More standardized methods in X. laevis |
For comprehensive OXNAD1 studies, researchers might consider using both species complementarily—X. tropicalis for genetic manipulation and X. laevis for biochemical and functional analyses .
Multiple experimental approaches have been documented for studying chemical interactions with OXNAD1:
Chemical Exposure Methods:
Based on studies of rat OXNAD1 that can be adapted to Xenopus models:
| Chemical | Effect on OXNAD1 | Experimental Approach | Reference |
|---|---|---|---|
| 17β-estradiol | Decreases expression | In vivo exposure followed by RT-qPCR | PMID:32145629 |
| 2,3,7,8-tetrachlorodibenzodioxine | Increases expression | In vivo exposure followed by RT-qPCR | PMID:33387578 |
| 6-propyl-2-thiouracil | Decreases expression | In vivo exposure followed by RT-qPCR | PMID:24780913 |
| All-trans-retinoic acid | Context-dependent | Co-treatment studies | PMID:36189433 |
Methodology for Xenopus Models:
Expose Xenopus embryos or tadpoles to the chemical of interest at appropriate developmental stages
Extract RNA from tissue samples
Perform RT-qPCR to quantify OXNAD1 expression changes
Compare to appropriate vehicle-treated controls
Consider co-exposure studies to investigate interaction effects
OXNAD1 functions as an oxidoreductase with a NAD-binding domain, suggesting important roles in redox processes:
Developmental Context:
Expression patterns across developmental stages can be studied using stage-specific RNA extraction and qPCR
Particular attention should be paid to metamorphosis, when significant oxidative stress occurs
OXNAD1's role can be examined in the context of tissue remodeling during metamorphosis
Experimental Approaches:
Loss-of-function studies: Using CRISPR/Cas9 to target OXNAD1 and assess effects on oxidative stress markers
Gain-of-function studies: Overexpressing OXNAD1 to determine protective effects against oxidative stressors
Chemical challenge experiments: Exposing embryos to oxidative stressors (H₂O₂, UVB radiation) with and without OXNAD1 manipulation
Cellular localization studies: Using tagged recombinant OXNAD1 to determine subcellular localization during stress response
Researchers studying OXNAD1 may encounter apparently contradictory results across different experimental setups. Several factors could explain these discrepancies:
Methodology Considerations:
Different detection methods (RNA-seq, microarray, qPCR) have varying sensitivities
Antibody specificities may differ between studies
RNA extraction methods can impact gene expression measurements
Biological Variables:
Developmental stage specificity: OXNAD1 expression varies significantly across developmental stages
Tissue-specific expression: Expression patterns may differ between tissues
Sex differences: OXNAD1 regulation may be different in males versus females
Environmental conditions: Temperature, pH, and other environmental factors can impact expression
Reconciliation Approach:
Carefully document all experimental conditions
Use multiple methods to validate findings (e.g., both RNA and protein quantification)
Include appropriate controls for developmental stage, sex, and tissue type
Consider the allotetraploid nature of X. laevis when interpreting gene expression data (potential homoeologs)
Essential Controls for OXNAD1 Studies:
Expression Controls:
Empty vector controls for overexpression studies
Non-targeting sgRNA/siRNA controls for knockdown studies
Validation of knockdown/overexpression by qPCR and western blot
Functional Assays:
Inclusion of known oxidative stress markers (e.g., catalase, SOD, GSH levels)
Positive controls for inducing oxidative stress (e.g., H₂O₂, paraquat)
Negative controls using antioxidants (e.g., N-acetylcysteine)
Developmental Controls:
Technical Controls:
OXNAD1's role in oxidative stress response makes it relevant to several human disease models that can be studied in Xenopus:
Cancer Research:
OXNAD1 could be studied in the context of cancer progression models in Xenopus
G3BP1, another gene involved in cancer that has been studied in oral squamous cell carcinoma, showed significant effects on cell survival when knocked down - similar approaches could be applied to OXNAD1
Mutations in chromosome 3, where human OXNAD1 is located, are associated with various cancer types
Neurodegenerative Disorders:
Oxidative stress is a key factor in neurodegenerative diseases
Xenopus brain models can be used to study OXNAD1's protective role against neurodegeneration
Recombinant rabies virus techniques could be adapted to study OXNAD1 in specific neural circuits
Aging-Related Conditions:
Given OXNAD1's differential expression with age, it could be a target for interventions against age-related conditions
The role of OXNAD1 in peripheral blood mononuclear cells (PBMCs) aging could be further explored in Xenopus immune system development
Developmental Disorders:
OXNAD1's potential role in congenital disorders could be modeled using CRISPR/Cas9 methodologies in Xenopus
Its connection to retinoic acid signaling pathways suggests potential implications for developmental abnormalities
Single-cell technologies offer powerful new approaches to understand OXNAD1 function:
Methodological Advances:
scRNA-seq in Xenopus tissues:
Can reveal cell-type specific expression patterns of OXNAD1
Allows tracking of expression changes during developmental transitions
Enables identification of co-expression networks and potential functional partners
Single-cell proteomics:
Could reveal post-translational modifications of OXNAD1
Helps identify cell-specific protein interactions
Provides insights into subcellular localization differences between cell types
Single-cell ATAC-seq:
Reveals chromatin accessibility at the OXNAD1 locus
Helps identify potential regulatory elements and transcription factors
Can track epigenetic changes during development or in response to stressors
Research Applications:
Mapping OXNAD1 expression across all cell types during metamorphosis could reveal previously unknown functions
Identifying cell populations most sensitive to OXNAD1 manipulation
Tracking real-time changes in OXNAD1 expression following oxidative stress in specific cell types